Teva buys Japanese drug company for $460 million
None
Teva Pharmaceuticals announced that it has signed a contract to buy 57% of the shares of the Japanese pharmaceuticals company Taiyo for $460 million. Taiyo is reportedly worth $1.3 billion. (Ynet)
